RecruitingPhase 2NCT06364384
Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
Studying Squamous cell carcinoma of the rectum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Principal Investigator
- Jun Huang, MD, M.DSixth Affiliated Hospital, Sun Yat-sen University
- Intervention
- PD-1 and CRT(combination_product)
- Enrollment
- 20 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06364384 on ClinicalTrials.gov